Andreas Vitalis originally studied Biochemistry in Bochum, Germany, where he quickly discovered his inclination toward theory and computation. After a year visiting the lab of Andy McCammon in San Diego, he began his Ph.D. in Molecular Biophysics under the supervision of Rohit Pappu at Washington University in St. Louis. His thesis work was motivated by trying to understand the physicochemical origins of polyglutamine repeat expansion diseases like Huntington's and led to a number of methodological advances in the field of molecular simulations, for which he is best-known today.
In 2009, Andreas Vitalis joined the Caflisch group at the Department of Biochemistry of the University of Zurich to pursue further studies of diseases characterized by protein and peptide aggregation (like Alzheimer's). Over years, he branched out into a number of additional fields covering a broad portfolio including high-performance computing, data science, drug discovery, or neuroscience. He is the primary developer of the molecular simulation software package CAMPARI (campari.sourceforge.net).
In 2018, he assumed the technical lead on the development of an in-house research and teaching platform providing an embedded, browser-based solution for performing molecular visualization, simulations, drug discovery, and analysis.
Andreas Vitalis is involved in the following modules:
Biochemistry lectures with exercises: BCH304 and BCH408